News
We explore the current guidance for osteoporosis screening in men, as well as barriers to access for both clinicians and ...
In an abrupt reversal, the US Department of Health and Human Services said Thursday that it no longer plans to cut funding ...
4h
News-Medical.Net on MSNNetwork pharmacology analysis reveals HXTL mechanism in treating postmenopausal osteoporosisHuo Xue Tong Luo Capsule (HXTL) has been clinically used to treat osteonecrosis of the femoral head, osteoporosis, and other bone and joint diseases with promising effects.
Denosumab plus romosozumab vs denosumab only was associated with improved bone mineral density among patients with severe ...
Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.
In postmenopausal patients with ulcerative colitis (UC) or Crohn’s disease (CD), approximately one-third had osteoporosis while approximately 40% had osteopenia. 2. In men aged over 50 years with UC ...
If you’re someone who’s at risk for developing osteoporosis, you’re probably well-accustomed to receiving regular bone density tests. Dual-energy X-ray absorptiometry (DEXA or DXA ...
Involvement of clinicians, including primary care physicians, endocrinologists, and rheumatologists, as appropriate, can ensure a comprehensive and personalized approach to managing osteoporosis and ...
today presented positive preclinical data demonstrating the satisfactory safety profile of its hydrocelin injectable ...
Find out why rheumatologists are your go-to doctors for autoimmune diseases like rheumatoid arthritis and gout. St. Luke’s rheumatologist Rajesh Kuupuraju breaks down the why of common autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results